MedTrace Logo

N-acetylcysteine in Bulimia Nervosa

NCT01131572 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2013-05-10

No results posted yet for this study

Summary

This study tests NAC in the treatment of Bulimia Nervosa.

Conditions

  • NAC

Interventions

DRUG

N-acetylcysteine NAC

N-acetylcysteine in the treatment of Bulimia Nervosa

Sponsors & Collaborators

  • Lindner Center of HOPE

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01131572 on ClinicalTrials.gov